A recent study found that the Autographa californica multiple nucleopolyhedrovirus (AcMNPV) Ac132 is a nucleocapsid-associated protein and required for budded virion (BV) production. We therefore initiated experiments aimed at understanding how Ac132 is involved in AcMNPV infection. An 80 bp region of ac132 was replaced with a chloramphenicol resistance gene to construct vAc132KO. Transfection of vAc132KO into Sf9 cells resulted in a single-cell infection phenotype, consistent with findings reported in a previous study. Interestingly, BVs were observable in the supernatants, and the BV production in the supernatant was comparable with that present in supernatants from a WT control. These results suggest that the ac132 deletion does not affect the egress of nucleocapsids from the transfected cells to form BVs, but the BVs are non-infectious. Transfection with DNA extracted from vAc132KO BVs could establish infection in Sf9 cells, indicating that the deletion does not affect the integrity of the viral genomic DNA in non-infectious progeny BVs. To monitor the traffic of nucleocapsids without Ac132, two mCherry proteins were fused with the major capsid protein VP39 to construct vAc132KO : 2mC. Using confocal microscopy, we observed that the nucleocapsids of vAc132KO : 2mC could not enter the nucleus and instead remained docked at the nuclear membrane. This study provides a new understanding of the nuclear entry of baculoviruses.
INTRODUCTION
Baculoviruses are a family of enveloped dsDNA viruses that infect insects of the orders Lepidoptera, Hymenoptera and Diptera (Rohrmann, 2013) . Based on their whole-genome sequences, the family Baculoviridae can be divided into four genera: Alphabaculovirus [lepidopteran nucleopolyhedroviruses (NPVs)], Betabaculovirus [lepidopteran granuloviruses (GVs)], Gammabaculovirus (hymenopteran NPVs) and Deltabaculovirus (dipteran NPVs). The members of the genus Alphabaculovirus [type species Autographa californica multiple nucleopolyhedrovirus (AcMNPV)] can be further subdivided into Group I and Group II (Jehle et al., 2006) . During the baculovirus infection cycle, two phenotypically distinct but genotypically identical progeny virions, budded virions (BVs) and occlusion-derived virions (ODVs), are produced. BVs are responsible for transmitting infection between susceptible insect tissues, whereas ODVs mediate horizontal virus transmission between insects.
Baculoviruses replicate in the nuclei of infected cells; therefore, their genomes must enter the host nucleus. Based on transmission electron microscopy observations, previous studies inferred that betabaculoviruses eject viral DNA through the nuclear pore complex (NPC), leaving an intact empty capsid on the cytoplasmic side of the NPC (Summers, 1971) . In contrast, alphabaculoviruses translocate intact DNA-containing nucleocapsids into the nucleus through the NPC, after which the nucleocapsid is uncoated and viral DNA is released (Au & Pant e, 2012; Ohkawa et al., 2010) . Although nuclear import is a vital event in the alphabaculovirus life cycle, the viral and cellular proteins involved in this process remain largely unknown.
In this study, an ac132-knockout virus (vAc132KO) was generated to investigate the role of ac132 in the AcMNPV life cycle. As expected, the deletion of ac132 results in a defect in cell-to-cell virus infection, which is consistent with findings reported in previous studies. Subsequently, we found that the major nucleocapsid protein VP39 was detected in supernatants from vAc132KO-transfected cells, and the amount of this protein present in the cell supernatants was similar to the amount present in supernatants from WT controls. Negative staining and electron microscopy confirmed the presence of BVs. Finally, we demonstrated that the nucleocapsids of vAc132KO : 2mC are unable to enter the cell nucleus.
RESULTS ac132 deletion leads to non-infectivity of AcMNPV BVs
The ac132 ORF is 660 bp in length. To generate the ac132-knockout bacmid bAc132KO, an 80 bp region of ac132 was replaced with a 1038 bp chloramphenicol resistance gene (Cm) via ET homologous recombination as previously described (Wu et al., 2006) . To avoid affecting neighbouring genes, 120 bp from the 5¢ end and 460 bp from the 3¢ end of ac132 were retained in the present study (Fig. 1) . The knockout region of ac132 was different from that reported by Yang et al. (2014) in which a 310 bp N-terminal fragment (Ac132 nt 1-310) was deleted from ac132. To determine whether the deletion of ac132 had any effect on occlusion body (OB) morphogenesis and to facilitate the examination of viral infection, the polyhedron gene (polh) of AcMNPV and the enhanced green fluorescence protein gene (egfp, referred to as gfp in this study) were inserted into the polh locus of bAc132KO via Tn7-mediated transposition as described previously (Wu et al., 2006) . Thus, an ac132-knockout AcMNPV, which we designated vAc132KO, was constructed. To confirm the phenotype resulting from the deletion of ac132, a rescue virus was generated by inserting a haemagglutinin (HA) epitopetagged ac132 ORF under the control of its native promoter together with the polh and gfp genes into the polh locus of bAc132KO, and the rescue virus was designated vAc132 : HA. To generate a WT control virus, the polh and gfp genes were inserted into the polh locus of bMON14272 (Luckow et al., 1993) ; the resulting virus was designated vAcWT (Fig. 1 ).
Sf9 cells were transfected with the recombinant viral DNAs and were monitored by fluorescence microscopy. At 24 h post-transfection (p.t.), no obvious differences in the number of fluorescent cells were observed, indicating that the transfection efficiencies of the three viruses were comparable ( Fig. 2a) . At 48 h p.t., a significant increase in the number of fluorescent cells was detected in the vAcWT-and vAc132 : HA-transfected cells. In contrast, the number of fluorescent cells in the vAc132KO-transfected cell population did not increase (Fig. 2a) . At 72 h p.t., fluorescence was observed in almost all of the cells transfected with vAcWT or vAc132 : HA; however, the fluorescence intensity of the cells transfected with vAc132KO remained unchanged (Fig. 2a) . These results suggest that the ac132 deletion affects the generation of infectious BVs (Fig. 2a) . Light microscopy showed that OBs were present in the transfected cells at 96 h p.t. (Fig. 2a) , indicating that the ac132 deletion does not affect the progression of infection to the very late phase. Titre assays showed that the kinetics of The 80 bp fragment of the ac132 ORF was replaced with a 1038 bp Cm cassette via ET homologous recombination to generate the ac132-knockout bacmid bAc132KO. The ac132-knockout virus (vAc132KO) was generated by inserting the polh and gfp genes into the polh locus of bAc132KO via Tn7-mediated transposition. Similarly, the ac132-repaired virus (vAc132 : HA) was generated by inserting the gene ac132 with HA, polh and gfp genes into the polh locus of bAc132KO; the WT control virus (vAcWT) was generated by inserting the polh and gfp genes into the polh locus of bMON14272.
the infectious BV production of vAc132 : HA and vAcWT were similar; however, no titre of vAc132KO BV could be detected at any time point up to 96 h p.t. (Fig. 2b) . Taken together, these results suggest that the ac132 deletion affects the generation of infectious BVs, which is consistent with those of a recent study (Yang et al., 2014) .
To investigate if there were any BV particles produced by vAc132KO, Western blotting was subsequently conducted to detect the presence of the major nucleocapsid protein VP39 and the BV envelope-specific protein GP64 in culture supernatants from vAc132KO-or vAcWT-transfected Sf9 cells. As shown in Fig. 2 (c), VP39 and GP64 were clearly detected in the culture supernatants of cells transfected with either of these viruses at 24 h p.t., and the protein levels were comparable. Using negative staining, we found that BVs were produced in the vAc132KO-transfected cells, and there were no discernible differences in BV morphology between vAc132KO and vAcWT (Fig. 2d) . Thus, although the deletion of ac132 does not affect BV production, the BVs produced by vAc132KO are non-infectious.
To further investigate whether ac132 deletion affects the integrity of the viral genomic DNA, viral genomic DNA extracted from vAc132KO BVs was transfected into Sf9 cells. As shown in Fig. 2 (e), fluorescence was detected in the transfected cells at 24 h p.t. (Fig. 2e) , indicating that the deletion of ac132 does not affect the integrity of the viral genomic DNA in non-infectious progeny BVs. However, the number of fluorescent cells did not increase at 72 h p.t. (Fig. 2e ), indicating that vAc132KO failed to establish a secondary infection. By contrast, infection by the WT control virus proceeded in a typical fashion.
Ac132 is a component of the nucleocapsid and the ODV envelope
BVs and ODVs were purified from vAc132 : HA-infected Trichoplusia ni larvae. The presence of Ac132 in virions was detected by Western blotting with a monoclonal anti-HA antibody. As shown in Fig. 3 (a), Ac132 was detected in both BVs and ODVs, consistent with the results of previous proteomic studies (Braunagel et al., 2003; Wang et al., 2010) . The virions were further fractionated into envelope and nucleocapsid fractions, and Ac132 was found to be associated with the nucleocapsids of both BVs and ODVs, and with the ODV envelope but not with the BV envelope ( Fig. 3a) . The effectiveness of the fractionation was confirmed by the detection of the major nucleocapsid protein VP39, the BV envelope-specific protein GP64 and the BV/ ODV envelope-associated protein ODV-E25 (Fig. 3a) .
Our finding that Ac132 is present in the envelope fraction of ODVs is inconsistent with results reported by Yang et al. (2014) in which Ac132 was not detected in the ODV envelope fractions. The sensitivity of the two antibodies may account for the difference. To further confirm our results, immunoelectron microscopy was performed with thin sections generated from vAc132 : HA-infected cells. As shown in Fig. 3 (b), immunogold-labelled Ac132 was specifically localized to the nucleocapsids within the electron-dense edges of the virogenic stroma (VS) (Fig. 3b, i) , the virusinduced intranuclear microvesicles (Fig. 3b , ii), and the nucleocapsid and the envelope of ODV in the ring zone ( Fig. 3b , iii). Immunogold-labelled Ac132 was not detected in the nuclear membrane. Very few gold particles were detected in control vAcWT-infected cells (data not shown). Taken together, the results from the Western blotting and the immunoelectron microscopy presented above suggest that Ac132 is a component of the nucleocapsid and the ODV envelope.
ac132 is required for nucleocapsid entry into the nucleus
To investigate the effects of the deletion of ac132 on AcMNPV infection, two recombinant viruses, vAc132KO : 2 mC and vAcWT : 2mC, were generated. In these recombinants, two mCherry proteins were fused with the major capsid protein VP39 to make it possible to monitor the traffic of nucleocapsids without or with Ac132, respectively, into the nucleus. BVs were harvested from Sf9 cells transfected with vAc132KO : 2mC or vAcWT : 2mC and used to inoculate fresh Sf9 cells. The infected cells were fixed and observed by confocal microscopy. Forty vAc132KO: 2mC-infected cells and 27 vAcWT : 2mC-infected cells were examined. In the cells infected with vAc132KO : 2mC, red signals, indicative of nucleocapsids, were detected on the plasma membrane, in the cytoplasm and on the edges of nuclei but not within the nuclei (Fig. 4a) . In contrast, in the cells infected with vAcWT : 2mC, nucleocapsids were observed in the cytoplasm and in the nucleus, as expected (Fig. 4a) , and nucleocapsids were observable in the nucleus in 57.14±12.37 % of the 27 cells examined (Fig. 4b) . These results suggest that the deletion of ac132 does not affect the entry of BVs into Sf9 cells but does impair the capacity of nucleocapsids to pass through the nuclear envelope.
Mutation of the SDXXYK motif affects infectious BV production
A SMART search showed that the 103-134 aa region of Ac132 is homologous to an NEBU domain that is known to bind actin (Pfuhl et al., 1996) . The NEBU domain is also present
Ac132 is a component of the nucleocapsid and the ODV envelope. (a) BVs and ODVs were purified from vAc132 : HAinfected T. ni larvae, and the purified virions were further fractionated into envelope and nucleocapsid fractions. Proteins were detected using Western blotting with anti-HA antibody to detect HA-tagged Ac132, anti-VP39 antibody to detect the major nucleocapsid protein VP39, anti-GP64 antibody to detect the BV envelope-specific protein GP64 and anti-ODV-E25 antibody to detect the BV/ODV envelope-associated protein ODV-E25. E, Envelope fractions; NC, nucleocapsid fractions. (b) Sf9 cells were infected with vAc132 : HA; at 72 h post-infection, the cells were processed for immunoelectron microscopy. Thin sections were stained with an anti-HA mAb at 1 : 50 dilution and with a secondary gold-conjugated antibody at 1 : 80 dilution. Gold particles were specifically localized to the nucleocapsids (black arrows) within the electron-dense edges of the virogenic stroma (VS) (i), the virus-induced intranuclear microvesicles (black triangles) (ii), and the nucleocapsids (black arrows) and envelopes (open arrows) of mature ODVs in the ring zone (iii). Bars, 200 nm.
in the Ac132 orthologs of BmNPV, Plutella xylostella multiple NPV (PlxyMNPV) and Rachiplusia ou multiple NPV (RoMNPV) as indicated by the red box (Fig. 5a ), but not present in other Group I alphabaculoviruses. A comparison of the predicted amino acid sequences showed that the NEBU domain contains a conserved SDXXYK motif (Fig. 5a ). Although the NEBU domain is only found in four closely related Group I baculoviruses, the conserved SDXXYK motif is also found in other Group I baculoviruses (Fig. 5a) -transfected Sf9 cells, and equal numbers of cells were fluorescent after transfection by either virus, indicating relatively similar efficiencies of transfection (Fig. 5b) . At 72 h p.t., the number of fluorescent cells increased slightly in the vAc132 : A 124/125 XXA 128/129 -transfected cells, whereas fluorescence spread throughout most of the vAcWT-transfected cells (Fig. 5b) , and the titre of vAc132 : A 124/125 XXA 128/129 was approximately 1000-fold lower than that of vAcWT (Fig. 5c) . These results indicate that the mutation of the SDXXYK motif significantly affects the ability of AcMNPV to infect cells.
DISCUSSION
ac132 is one of the 12 genes that are conserved in and unique to all Group I alphabaculovirus genomes sequenced to date. The conservation of the ac132 gene suggests that it may play a crucial role in virus replication. Specifically, ac132 was recently shown to be an essential gene, and its product was characterized as a component of the viral nucleocapsid (Yang et al., 2014) . However, what role ac132 plays in viral replication remains unknown. In the present study, a recombinant AcMNPV, vAc132KO, was constructed, in which a small region of ac132 (ac132 nt 121-200) was replaced with a Cm gene. Consistent with a previous report by Yang et al. (2014) , the ac132 deletion led to a defect in the transmission of viral infection (Fig. 2a) but the deletion had no effect on viral morphogenesis (data not shown). Whether the phenotypic differences between the current study and the previous report by Yang et al. (2014) were due to the slight difference of Ac132 knockout region remains to be determined. Further investigation by our group showed that BVs were present in the culture supernatant of vAc132KO-infected cells; however, the BV progeny of the mutant virus were non-infectious (Fig. 2c, d ).
Previous studies showed that Ac132 is associated with both BVs and ODVs (Braunagel et al., 2003; Wang et al., 2010; Yang et al., 2014) . In the present study, Ac132 was further confirmed to be a component of the nucleocapsid by Western blotting (Fig. 3a) . Mutations of viral structural proteins generally lead to impairment in the packaging, assembly or structural integrity of the nucleocapsid; to alterations in the transport or egress of nucleocapsids within the cell; or to defects in intranuclear microvesicle formation, ODV envelopment or the subsequent embedding of virions into OBs. Interestingly, in contrast to the deletions of the other nucleocapsid proteins, deletion of ac132 did not affect viral morphogenesis. This finding implies that Ac132 is a nucleocapsid protein that is essential to viral infectivity rather than to virion assembly. Western blotting results showed that Ac132 is a component not only of the nucleocapsid but also of the ODV envelope. Localization of Ac132 to the nucleocapsid and the ODV envelope was further demonstrated using immunoelectron microscopy. In AcMNPV, VP80 is in a complex along with actin that is involved in the polar transport of nucleocapsids out of their assembly sites to the periphery of the nucleus (Marek et al., 2011) . Like Ac132, VP80 was also found to be located in the envelope fraction of ODV (Hou et al., 2013) . The biological significance of such proteins that can be a nucleocapsid component and an ODV envelope component remains unknown.
BVs in the supernatant of vAc132KO-transfected cells were non-infectious but had a normal appearance. It would be of interest to determine why the vAc132KO virus is non-infectious. The presence of GP64 in the vAc132KO BVs strongly suggests that the deletion of ac132 did not affect the binding of vAc132KO BVs to host cells or the release of nucleocapsids into the cytoplasm. Previous findings have shown that AcMNPV nucleocapsids enter the nucleus through nuclear pores (Ohkawa et al., 2010) and that actin cables are crucial for the efficient translocation of the nucleocapsids to the nucleus (Lanier & Volkman, 1998) . In the present study, virions could be observed in the cytoplasm and on the edge of the nucleus, but not within the nucleus, after ac132 deletion (Fig. 4) . Thus, Ac132 may be required for the transport of the nucleocapsid into the nucleus through nuclear pores. Previous work has shown that ac109-knockout viruses show a phenotype similar to that of the ac132 deletion mutant used in this work (Alfonso et al., 2012; Fang et al., 2009; Lehiy et al., 2013) . It would therefore be interesting to determine whether Ac132 interacts with Ac109 and to elucidate the precise role of each of these viral proteins in the transport of nucleocapsids through the nuclear pores.
Nebulin is a 600-800 kDa protein found in the thin filaments of vertebrate striated muscle; up to 97 % of the nebulin sequence consists of repeats of a 35 aa motif referred to as the NEBU domain. The tandem arrays produced by this motif are presumed to play a role in binding and stabilizing F-actin (Pfuhl et al., 1996) . Actin-based motility plays a role in the transit of baculovirus nucleocapsids to the nucleus (Ohkawa et al., 2010) . While visualizing movements in the vicinity of the nucleus, Ohkawa et al. (2010) noticed that nucleocapsids frequently collided with and stuck to the nuclear periphery. Strikingly, these viruses continued to polymerize actin, which radiated from the nucleus and underwent corkscrew-like motions (Ohkawa et al., 2010) . In the present study, a potential NEBU domain was found in Ac132 in which the mutation of the hallmark motif SDXXYK resulted in a significant reduction of BV production. It is therefore intriguing to speculate that Ac132 may play a role in binding and stabilizing F-actin in the infected cell. After nucleocapsids are released into the cytoplasm during infection, the naked nucleocapsids are quickly transported to the nuclear periphery and dock at the cytoplasmic filaments of nuclear pore complexes prior to entering the nucleus through the nuclear pores. We speculate that the NEBU domain of Ac132 may stabilize F-actin, which might attach to nucleocapsids and then push the nucleocapsids into the nucleus.
In summary, the results of this study show that Ac132 plays a role in the entry of viral nucleocapsids into the nucleus. This finding broadens our understanding of the baculovirus infection pathway and provides a better understanding of the transport of nucleocapsids through the nuclear pore complex. In the biomedical field, baculoviruses are well known as potent protein expression vectors and gene therapy vectors (Cox, 2012; Rivera-Gonzalez et al., 2011) . Understanding the mechanism of the nuclear import of baculoviruses will facilitate the use of baculoviruses as efficient vectors.
METHODS
Cell lines and viruses. The Sf9 cell strain, which was derived from Spodoptera frugiperda (Vaughn et al., 1977) , was cultured at 27 C in TNM-FH medium (Invitrogen) supplemented with 10 % FBS, 100 µg penicillin ml À1 and 30 µg streptomycin ml
À1
. The bacmid bMON14272 (Invitrogen), containing an AcMNPV genome, was propagated in the Echerichia coli strain DH10B as previously described (Luckow et al., 1993) . BV titres were determined with a 50 % TCID 50 endpoint dilution assay in Sf9 cells (O'Reilly et al., 1992) .
Construction of an ac132-knockout bacmid. An ac132-knockout AcMNPV bacmid was generated via ET homologous recombination as previously described (Wu et al., 2006) . Briefly, a transfer vector in which an ac132 locus region was replaced with a Cm gene for antibiotic selection in Escherichia coli was constructed as follows. Using primers ac132US1 [5¢-GAGCTCGACCAGATTAAACACATTGCTTGCC-3¢ (the SacI site is underlined)] and ac132US2 [5-GGATCCAGCGATGGC TTTCTTGTAT TGCTGC-3¢ (the BamHI site is underlined)], a 461 bp fragment homologous to the 5¢ region of the ac132 ORF (AcMNPV nt 117 008-117 468) was PCR-amplified from bMON14272. Similarly, a 490 bp fragment homologous to the 3¢ region of the ac132 ORF (AcMNPV nt 117 549-118 038) was PCR-amplified using primers ac132DS1 [5¢-CTGCAGAAGATTAGAGAATGCAGTTGTAGTA-3¢ (the PstI site is underlined)] and ac132DS2 [5¢-AAGCTTCATGATG TCGACGTGCTAGCCTTAC-3¢ (the HindIII site is underlined)]. The PCR products were cloned into the pUC18-Cm plasmid (Wu et al., 2006) to generate a transfer vector named pUC18-ac132UCD. pUC18-ac132UCD was then digested with SacI and HindIII, and the resulting 1989 bp DNA fragment containing the Cm gene cassette and the ac132 flanking region was gel-purified and transformed into electrocompetent DH10Bac cells as previously described (Wu et al., 2006) . The recombination was analysed by PCR, and the resulting bacmid was designated bAc132KO.
Construction of an ac132-knockout virus. To facilitate the examination of viral infection and to determine whether the ac132 deletion has any effect on OB morphogenesis, the gfp and polh genes were transposed into bAc132KO by site-specific transposition as previously described (Yuan et al., 2011) ; the resulting ac132-knockout virus was designated vAc132KO. Similarly, the polh and gfp genes were transposed into bMON14272 to generate a WT control virus (vAcWT).
A repaired virus that ectopically expresses ac132 was constructed as follows. A DNA fragment containing the ac132 native promoter, the ac132 ORF and an HA epitope tag at the Ac132 N terminal was PCR-amplified from bMON14272 using primers ac132RU [5¢-GAGCTCTACCC GACTTGACGTCCATGTTAGA-3¢ (the SacI site is underlined)] and ac132RHA [5¢-GGATCCCTAGGC GTAATCTGGGACGTCGTATGGG TAAAGACCTAATGGTAAAATGACG-3¢ (the BamHI site is underlined, and the bold letters indicate the HA sequences)]. The PCR products were cloned into the pUC18-SV40 plasmid (Cai et al., 2012) to generate pUC18-Ac132 : HA-SV40. pUC18-Ac132 : HA-SV40 was digested with SacI and XbaI, and the resulting fragment was inserted into pFB1-PH-GFP (Wu et al., 2006) to generate the donor plasmid pFB1-Ac132 : HA-PG. The ac132 gene cassette was transposed into bAc132KO as described above, and the resulting ac132-repaired virus was designated vAc132 : HA.
All recombinations of the constructed viruses were confirmed by PCR and DNA sequencing. The selection of colonies that were free of pMON7124 was performed as previously described (Wu et al., 2006) . Bacmid DNA was purified using a Qiagen Large-Construct kit and was quantified using the optical density method.
Analysis of viral growth. Sf9 cells (1.0Â10 6 ) were transfected with 1.0 µg of the constructed bacmid (vAcWT, vAc132KO or vAc132 : HA) using the Cellfectin liposome reagent (Invitrogen) in triplicate. At the time points indicated p.t., cells were observed with a fluorescence microscope (ECLIPSE TE2000-U; Nikon), and supernatants were harvested to determine titres.
BV concentration and negative staining. Sf9 cells (1.0Â10 6 ) were transfected with 1.0 µg of the constructed bacmid (vAc132KO or vAcWT). At 24 h p.t., BVs were purified as previously described (Yuan et al., 2011) . To determine whether any non-infectious BVs were produced in vAc132KO-transfected cells, Western blotting was performed using a polyclonal anti-AcMNPV VP39 antibody (1 : 2000) (Li et al., 2007) or a monoclonal anti-GP64 AcC6 antibody (1 : 2000; eBioscience) as the primary antibody and a donkey anti-rabbit HRP-conjugated antibody (1 : 10 000; Amersham Biosciences) or goat anti-mouse HRP-conjugated antibody (1 : 3000; Pierce) as the secondary antibody. Proteins were visualized using an enhanced chemiluminescence system (ECL; Amersham Biosciences) according to the manufacturer's instructions. To investigate whether the mutant viruses exhibited any structural abnormalities, the BVs of vAc132KO were purified and negatively stained as previously described (Fang et al., 2009 ).
Viral DNA extraction. Sf9 cells (1.0Â10 6 ) were transfected with 1.0 µg of vAc132KO or vAcWT. At 24 h p.t., the supernatants were harvested for BV purification. Viral DNA was isolated from the BVs as previously described (Wang et al., 2011) .
Purification of BVs and ODVs. Third-instar T. ni larvae were infected by the contamination of an artificial diet with vAc132 : HA OBs prepared from vAc132 : HA-infected cells. BVs were collected by extracting haemolymph from infected larvae 3 days post-infection (p.i.). OBs were isolated and purified from dead larvae (Wu et al., 2008) . BVs and ODVs were purified and fractionated into envelopes and nucleocapsids as previously described (Yuan et al., 2011) . Western blotting was performed using one of the following primary antibodies: mouse monoclonal anti-HA antibody, monoclonal anti-GP64 AcC6 antibody, polyclonal anti-AcMNPV ODV-E25 antibody (1 : 2000) (Wang et al., 2010) or polyclonal anti-AcMNPV VP39 antibody. A donkey anti-rabbit HRP-conjugated antibody or goat anti-mouse HRP-conjugated antibody was used as the secondary antibody.
Immunoelectron microscopy. Sf9 cells (1.0Â10 6 ) were infected with vAc132 : HA at an m.o.i. of 5 TCID 50 per cell. At 72 h p.i., the cells were dislodged and pelleted at 800 g for 10 min. Immunoelectron microscopy was performed as described previously (Wei et al., 2013) .
Analysis of virion entry. To investigate nucleocapsid transport in ac132-knockout virus-infected cells, a second copy of the VP39 protein fused with two mCherry proteins was introduced into bAc132KO by site-specific transposition as follows. Using the primers vp39U [5¢-CGGAATCCATATCTTGTTCGCCATCGTG-3¢ (the EcoRI site is underlined)] and vp39D [5¢-ACGCGTCGACGACGGCTATTCCTCCACC TG-3¢ (the SalI site is underlined)], a DNA fragment containing vp39 with its own promoter sequence was PCR amplified. Similarly, using the primers mCherryU1 [5¢-ACGCGTCGACGGTGGCTCTGGATC TGGCGG-3¢ (the SalI site is underlined)] and mCherryD1 [5¢-GGGG TACCCTTGTACAGCTCGTCCATGC-3¢ (the KpnI site is underlined)], a DNA fragment containing the mCherry ORF was amplified from the plasmid pCMV-mCherry (Clontech). Another mCherry DNA fragment was amplified using primers mCherryU2 [5¢-GGGGTACCGGTGGCTC TGGATCTGGCGG-3¢ (the KpnI site is underlined)] and mCherryD2 [5¢-CCCAAGCTTCTTGT ACAGCTCGTCCATGC-3¢ (the HindIII site is underlined)]. The three DNA fragments were digested with the corresponding enzymes and successively cloned into pFastBac1 (Invitrogen) to generate the donor plasmid pFB1-VP39-2mCherry. pFB1-VP39-2mCherry was site-specifically transposed into bAc132KO and bMON14272 as described above; the resulting viruses were designated vAc132KO : 2mC and vAcWT:2mC, respectively. Sf9 cells (3.0Â10 5 ) were chilled at 4 C for 30 min and then infected with 1 ml of culture supernatant containing vAc132KO : 2mC BVs or vAcWT : 2mC at an m.o.i. of 0.1 TCID 50 per cell. After incubation of the cells for 90 min at 4 C, the inoculum was removed and the cells were washed twice with chilled TNM-FH medium and shifted to 27 C in TNM-FH medium supplemented with FBS, penicillin and streptomycin. After incubation at 27 C for 90 min, the cells were fixed with 4 % paraformaldehyde and examined with a Zeiss 7 DUO NLO confocal microscope using a Â63 oil immersion objective. To identify Ac132 homologues, the Ac132 amino acid sequence was searched against non-redundant protein sequences in the National Center for Biotechnology Information (NCBI) database using the position-specific iterated (PSI) BLAST algorithm. Multiple sequence alignments were performed using CLUSTAL X (Larkin et al., 2007) and edited using GeneDoc (Nicholas et al., 1997) . The presence of an NEBU domain was predicted by a SMART (Letunic et al., 2009) XXA 128/129 by using site-directed, ligase-independent mutagenesis as described previously (Chiu et al., 2004) . The primers ac132-SDXXYK-Ft (5¢-TGCTGCAAG TAATGCTGCTCTGATTCTGGCACATTCTAGT-3¢), ac132-SDXXYKFs (5¢-TCTGATTCTGGCACATTCTAGT-3¢), ac132-SDXXYK-Rt (5¢-GCAGCATTACTTGCAGCAAACAAAAACGAAGTCGCTAT-3¢) and ac132-SDXXYK-Rs (5¢-AACAAAAACGAAGTCGCTAT-3¢) were used, and the plasmid pUC18-Ac132 : HA-SV40 was used as the template. The PCR products were digested with DpnI (NEB) and hybridized to generate the plasmid pUC18-Ac132 : A XXA 128/129 was generated by site-specific transposition as described above.
